Tag Archive | "Dealdoc"

Acquisition agreement for Micromet

Tags: , , ,


Amgen and Micromet have entered into a definitive merger agreement under which Amgen will acquire Micromet for $11 per share in cash Read the full story

Acquisition agreement for Pharmasset

Tags: , , , , , ,


Definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash Read the full story

Acquisition agreement for Adolor

Tags: , , ,


Definitive agreement under which Cubist will acquire all of the outstanding shares of Adolor for $4.25 per share in cash Read the full story

Licensing agreement for Folate Binding Protein-E39 (FBP) targeted vaccine

Tags: , , ,


Licensed worldwide rights to develop and commercialize a Folate Binding Protein-E39 (FBP) targeted vaccine to prevent recurrence in gynecological cancers Read the full story

Acquisition agreement for PPD

Tags: ,


Definitive merger agreement under which it will be acquired by affiliates of The Carlyle Group and Hellman & Friedman Read the full story

Getinge gets Atrium Medical in $680 million acquisition

Tags: , ,


Swedish medical technology company Getinge has announded the acquisiton of US cardiovascular company Atrium Medical in a deal valued at $680 million Read the full story

Acquisition agreement for Azur Pharma

Tags: ,


Jazz Pharmaceuticals and Azur Pharma Limited have agreed to combine in an all-stock transaction Read the full story

Acquisition agreement for Azur Pharma

Tags: ,


Jazz Pharmaceuticals and Azur Pharma Limited have agreed to combine in an all-stock transaction that creates a specialty pharmaceutical company incorporated in Ireland with a diversified portfolio of products currently marketed in the United States (US).   Read the full story

Acquisition agreement for Elan Drug Technologies

Tags: ,


AlkermesElan Drug Technologies: Cash and stock transaction currently valued at approximately $960 million Read the full story

Alkermes and Elan complete merger between Alkermes and EDT, valued at $960m

Tags: ,


Cash and stock transaction currently valued at approximately $960 million.  Read the full story

cpbannerad300x150new2gif
strategicalliances082114jpg
currentpartneringpharma-bio300x150gif
RSS Feed Linked In Twitter

Latest Tweets

cabannerad300x150new4gif
2014-pmr-eur-banner-300x150gif
currentpartneringpharma-bio300x150gif